Document Detail


Effect of hydroxyapatite nanoparticles on the ultrastructure and function of hepatocellular carcinoma cells in vitro.
MedLine Citation:
PMID:  18458384     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The interaction of Bel-7402 hepatocellular carcinoma cells (HCC) as a single cell suspension with hydroxyapatite (HAP) nanoparticles was investigated. It was observed by an inverted microscope that the cells were still homogeneously distributed in the culture medium after 24 h. A TEM analysis showed that the HAP nanoparticles attached to the Bel-7402 cells were finally swallowed by the cells after 4 h, and induced ultrastructural changes of the cells after 4 days. A MTT assay and cell count test for the HAP nanoparticles of various concentrations from 0.14 to 0.56 mmol L(-1) showed that the HAP nanoparticles at a concentration of 0.56 mmol L(-1) induced the strongest effect on the inhibition of Bel-7402 cell proliferation and induced a dramatic decline in cell numbers. Proliferation of Bel-7402 was inhibited by more than 70%, compared to the control. A cell cycle analysis revealed that HAP can arrest Bel-7402 cells at the G1 phase with increasing effect over time. These findings demonstrated that HAP can enter into HCC very easily, change their ultrastructure, and evidently suppress their proliferation.
Authors:
Mei-Zhen Yin; Ying-Chao Han; Ingo W Bauer; Pei Chen; Shi-Pu Li
Related Documents :
15041224 - The occurrence of chromosome segregational defects is an intrinsic and heritable proper...
18483314 - Vitamin d3 analogue eb1089 inhibits the proliferation of human laryngeal squamous carci...
1392514 - Ultrastructure and cell surface studies of cancer cells following vitamin c administrat...
18952074 - Aldehyde dehydrogenase activity as a functional marker for lung cancer.
3831214 - Evidence for the role of fibronectin in amphibian gastrulation.
25205844 - Microfluidic isolation of cd34-positive skin cells enables regeneration of hair and seb...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-03-15
Journal Detail:
Title:  Biomedical materials (Bristol, England)     Volume:  1     ISSN:  1748-605X     ISO Abbreviation:  -     Publication Date:  2006 Mar 
Date Detail:
Created Date:  2008-05-06     Completed Date:  2008-05-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101285195     Medline TA:  Biomed Mater     Country:  England    
Other Details:
Languages:  eng     Pagination:  38-41     Citation Subset:  IM    
Affiliation:
Center of Biomedical Material and Engineering, Wuhan University of Technology, Wuhan 430070, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Carcinoma, Hepatocellular / drug therapy,  pathology,  physiopathology*
Cell Line, Tumor
Cell Survival / drug effects
Durapatite / administration & dosage*,  chemistry*
Humans
Liver Neoplasms / drug therapy,  pathology,  physiopathology*
Materials Testing
Nanoparticles / administration & dosage*,  chemistry*,  ultrastructure
Particle Size
Chemical
Reg. No./Substance:
1306-06-5/Durapatite

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acceleration of wound healing in traumatic ulcers by absorbable collagen sponge containing recombina...
Next Document:  Comparison of two types of alginate microcapsules on stability and biocompatibility in vitro and in ...